Narirutin mitigates osteoarthritis by targeting USP15 to promote KEAP1 degradation and suppress chondrocyte ferroptosis.
- DOI
- 10.1016/j.intimp.2026.117454
- Published
- 2026 Sep 25
- Container
- International immunopharmacology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.intimp.2026.117454,
title = {Narirutin mitigates osteoarthritis by targeting USP15 to promote KEAP1 degradation and suppress chondrocyte ferroptosis.},
author = {Zhang X and Ying S and Tu Y and Zhou C and Zheng S and Gao C and Hu Q and Xie C and Pan X},
year = {2026},
journal = {International immunopharmacology},
doi = {10.1016/j.intimp.2026.117454},
url = {https://doi.org/10.1016/j.intimp.2026.117454}
}RIS
TY - JOUR TI - Narirutin mitigates osteoarthritis by targeting USP15 to promote KEAP1 degradation and suppress chondrocyte ferroptosis. AU - Zhang X AU - Ying S AU - Tu Y AU - Zhou C AU - Zheng S AU - Gao C AU - Hu Q AU - Xie C AU - Pan X PY - 2026 JO - International immunopharmacology DO - 10.1016/j.intimp.2026.117454 UR - https://doi.org/10.1016/j.intimp.2026.117454 ER -
APA
X, Z., S, Y., Y, T., C, Z., S, Z., C, G., Q, H., C, X., & X, P. (2026). Narirutin mitigates osteoarthritis by targeting USP15 to promote KEAP1 degradation and suppress chondrocyte ferroptosis.. International immunopharmacology. https://doi.org/10.1016/j.intimp.2026.117454
Source records
- pubmed · retrieved 2026-09-26T15:51:21.328Z